Global Vision Technologies Selected as Patient Registry Software Provider - PDT Research at Ohio State University Comprehensive Cancer Center (OSUCCC-James)
Posted on: Wednesday, 14 October 2009, 05:00 CDT
ST. LOUIS and COLUMBUS, Ohio, Oct. 14 /PRNewswire/ -- The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) has entered into a contract with Global Vision Technologies (GVT) to create and deliver a new, web-based Photo Dynamic Therapy patient registry solution -- ClinicalPURSUIT -- to help streamline the data collection and outcomes analysis process.
Photodynamic therapy (PDT) is a treatment that uses drugs, called photosensitizing agents, along with light to kill cancer cells. Depending on the part of the body being treated, the photosensitizing agent is either injected into the bloodstream or put on the skin. Over a certain amount of time the drug is absorbed by the cancer cells. Then light is applied to the area to be treated. The light causes the drug to react with oxygen, which forms a chemical that kills the cancer cells.
Today, expensive market research and time-to-ramp-up delays are two costly issues confronting medical research teams, medical centers and pharmaceutical organizations. With ClinicalPURSUIT, GVT delivers a powerful, cost-effective patient registry software tool that will help OSUCCC-James work with real-time, accurate information on their patients daily.
"ClinicalPURSUIT is a HIPAA compliant, tailored patient registry solution and is built on GVT's Vision Server .NET architecture -- which allows for rapid development and customization. The new patient registry tool enables our clients to collect data securely and rapidly from multiple centers in a collaborative effort. The data can then be compiled, accessed and analyzed giving valuable insight into what's working and how to further improve the outcomes of patients," remarked George Ritacco, Executive Director, Client Services at GVT.
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute and ranked by U.S. News & World Report as among the top 20 cancer hospitals in the nation.
GVT has also written a free strategy guide and blueprint to building a registry titled, "The Patient Registry Manifesto". To download the guide -- visit www.strategicpatientregistry.com
GVT is a provider of world-class information management solutions for patient registries (ClinicalPURSUIT), child welfare case management software (FAMCare) and e-learning management solutions (OmniTrackPlus). For further information, please contact George Ritacco at 877-791-4367 ext. 85
Website: http://www.globalvisiontech.com
ClinicalPURSUIT: http://www.patientregistrysoftware.com/PatientRegistry/ClinicalPURSUIT/tabid/171/Default.aspx
This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.
SOURCE Global Vision Technologies, Inc.
Source: PR Newswire
Related Articles
- Beth Israel Medical Center Receives Major American Cancer Society Grant Toward Improving Pain Management in Chinese Cancer Patients
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
- Patient-centered Approach To Obtain Data From Cancer Patients Improves Care And Research
- Thomson Reuters and the National Foundation for Cancer Research Provide Online Help for Cancer Patients
- Neuroscientists Offer Hope for Breast Cancer Patients Suffering From 'Chemobrain'
- The Molecular Profiling Institute Launches Mammostrat(TM) - A Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients
- Researchers From Erasmus Cancer Center Validate the Clinical and Prognostic Utility of the HOXB13/IL17BR Ratio in Breast Cancer Patients
- Virus Found in Some Cancer Patients: ; Research Opens Up New Avenues for Battling Prostate Cancer
- Virus Found in Prostate Cancer Patients
- Diagnostic Criteria for Psychosomatic Research and Psychosocial Variables in Breast Cancer Patients
User Comments (0)

RSS Feeds